ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,568.90
-0.20%
Gold vs US Dollar
2,334.80
1.40%
Brent Oil
82.425
0.55%
Bitcoin
65,454.66
-1.95%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Windtree Therapeutics Inc (WINT) Share Price

WINT Windtree Therapeutics Inc

3.2195
0.2295 (7.68%)
Last Updated: 19:52:31
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Windtree Therapeutics Inc NASDAQ:WINT NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.2295 7.68 3.2195 3.16 3.22 3.6708 2.92 2.92 70,570 18:52:31   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics  -20.29M -3.9414 -0.81 16.47M
 Type  Size  Price  Time  Units 
 9 10 3.21 18:54:07 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore WINT News
15/05/202421:59EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202413:41EDGAR2Form S-1 - General form for registration of securities under the Securities Act of 1933
07/05/202413:00GLOBEWindtree Therapeutics Regains Compliance with Nasdaq
18/04/202413:00GLOBEWindtree Therapeutics Announces Reverse Stock Split
17/04/202413:00GLOBEWindtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
08/04/202421:48GLOBEWindtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing
16/02/202422:07EDGAR2Form 8-K - Current report
Period
Draw mode
Data Downloads for WINT

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Windtree Therapeutics Inc Articles